All News

European policymakers are largely to blame for the sorry state of innovation in Europe, according Microsoft’s chief research and strategy officer.

While analysts have been focusing on Asian investment in R&D, its actual research output has been missing from their radar screens. They need to refocus.

The European Science Foundation is to help the ten central and eastern European countries integrate their social sciences into the enlarged European Research Area.

The US biotechnology industry has gone through more than three years of sustained IPO financings, but that news isn’t all rosy for the industry.

IPOs are up in the year to date. But the value of these deals is down. Rather than cashing out, VCs are getting a ticket to stay on for a white-knuckle ride.

The technology funding gap has long been with us, but in drug discovery it has widened into a chasm.